No, I believe regulatory approval(s) should be the trigger to consummate then announce a deal. If DCVax-L is not approved for any reason, and NWBio had already announced a deal, that would be a legal nightmare, and grounds for several class-action lawsuits.
NWBio should continue doing what they are doing (focusing on multiple application submissions and regulatory approvals for DCVax-L), then everything else will fall into place in due time.
They should not announce something just to provide a short-term rise in the stock price.
News 
Market Data 
Discover 
AI
